Mesothelioma Navy Asbestos-Related Diseases & Health Effects 2 — Questions and Answers
Question 1: How does mesothelioma differ from asbestos-related lung cancer?
- Mesothelioma originates in the lung tissue itself, while asbestos lung cancer affects the pleura
- Mesothelioma arises from the mesothelial lining of body cavities, while asbestos lung cancer develops within the lung parenchyma (Correct answer)
- Asbestos lung cancer requires greater exposure levels than mesothelioma to develop
- Mesothelioma is always caused by cigarette smoking combined with asbestos exposure
Correct answer: Mesothelioma arises from the mesothelial lining of body cavities, while asbestos lung cancer develops within the lung parenchyma
Mesothelioma arises from the mesothelial cells lining body cavities (pleura, peritoneum, pericardium), while asbestos-related lung cancer develops within the lung tissue (parenchyma) itself.
Question 2: Which of the following is considered a benign (non-cancerous) asbestos-related condition?
- Malignant pleural mesothelioma
- Adenocarcinoma of the lung
- Pleural plaques (Correct answer)
- Peritoneal mesothelioma
Correct answer: Pleural plaques
Pleural plaques are a benign, non-cancerous manifestation of asbestos exposure, representing localized fibrous deposits on the parietal pleura.
Question 3: What is the primary pathological process in asbestosis?
- Chronic inflammation leading to pleural effusion
- Progressive pulmonary fibrosis caused by accumulated asbestos fibers (Correct answer)
- Neoplastic transformation of mesothelial cells
- Granuloma formation similar to sarcoidosis
Correct answer: Progressive pulmonary fibrosis caused by accumulated asbestos fibers
In asbestosis, the body's immune response to inhaled asbestos fibers triggers progressive pulmonary fibrosis (scarring), which gradually reduces lung capacity and oxygen exchange.
Question 4: Which imaging study is most commonly used as an initial screening tool for asbestos-related lung disease?
- PET scan
- MRI of the thorax
- Chest X-ray (CXR) (Correct answer)
- Ultrasound of the chest wall
Correct answer: Chest X-ray (CXR)
Chest X-ray (CXR) is the most widely used initial screening tool for detecting asbestos-related lung diseases such as pleural plaques, asbestosis, and pleural effusions.
Question 5: What symptom is most characteristic of advanced asbestosis?
- Sharp pleuritic chest pain
- Hemoptysis (coughing up blood)
- Progressive exertional dyspnea (shortness of breath with activity) (Correct answer)
- Sudden onset of chest tightness at rest
Correct answer: Progressive exertional dyspnea (shortness of breath with activity)
Progressive exertional dyspnea is the hallmark symptom of asbestosis, worsening over time as pulmonary fibrosis reduces the lungs' ability to expand and exchange oxygen effectively.
Question 6: Where does peritoneal mesothelioma develop?
- In the pleura, the lining of the lungs
- In the peritoneum, the lining of the abdominal cavity (Correct answer)
- In the pericardium, the sac surrounding the heart
- In the tunica vaginalis, the lining of the testis
Correct answer: In the peritoneum, the lining of the abdominal cavity
Peritoneal mesothelioma develops in the peritoneum, the membrane lining the abdominal cavity, and accounts for approximately 20–25% of all mesothelioma cases.
Question 7: The dose-response relationship in asbestos exposure means:
- A single brief exposure is sufficient to guarantee disease development
- Higher cumulative asbestos exposure generally correlates with greater disease risk (Correct answer)
- Disease risk is identical regardless of the amount or duration of exposure
- Only direct physical contact with raw asbestos products causes disease
Correct answer: Higher cumulative asbestos exposure generally correlates with greater disease risk
The dose-response relationship indicates that greater cumulative asbestos exposure (higher doses accumulated over time) generally corresponds to a higher risk of developing asbestos-related diseases.
Mesothelioma Navy Asbestos-Related Diseases & Health Effects 2
How does mesothelioma differ from asbestos-related lung cancer?